PROCEPT BioRobotics Corporation (BMV:PRCT)
543.54
+7.54 (1.41%)
At close: Jan 22, 2026
PROCEPT BioRobotics Company Description
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally.
The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia.
It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia.
PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
PROCEPT BioRobotics Corporation
| Country | United States |
| Founded | 2007 |
| Industry | Surgical and Medical Instruments and Apparatus |
| Employees | 756 |
| CEO | Larry Wood |
Contact Details
Address: 150 Baytech Drive San Jose, California 95134 United States | |
| Phone | 650 232 7200 |
| Website | procept-biorobotics.com |
Stock Details
| Ticker Symbol | PRCT |
| Exchange | Mexican Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Larry Wood | Chief Executive Officer |
| Kevin Waters | Chief Financial Officer |
| Christofer Christoforou | Chief Operating Officer |
| Matthew Bacso | Head of Investor Relations |